Literature DB >> 11246238

Complications of cardiac catheterization in the current era: a single-center experience.

B Chandrasekar1, S Doucet, L Bilodeau, J Crepeau, P deGuise, J Gregoire, R Gallo, G Cote, R Bonan, M Joyal, G Gosselin, J F Tanguay, I Dyrda, M Bois, A Pasternac.   

Abstract

Consecutive cardiac catheterization procedures done over a 2-yr period (April 1996 to March 1998) were prospectively analyzed to determine and characterize procedure-related complications (in-hospital and 1-mo follow-up), as they occur at present. During the study period, 11,821 procedures (7,953 diagnostic and 3,868 therapeutic) were performed. The majority of procedures (> 60%) were done in high-risk patients. Stents were implanted in 33% of patients, and adjunctive abciximab was used in 6.6% of therapeutic procedures. The overall complication rate was 8% (3.6% of diagnostic procedures and 15.1% of therapeutic procedures). The procedure-related mortality rates were 0.2%, 0.1%, and 0.5% for total, diagnostic, and therapeutic procedures, respectively. Cardiac complications were seen in 3.9% (1.5% of diagnostic and 9% of therapeutic procedures). Emergency cardiac surgery was required in 0.05% of the diagnostic procedure group and 0.3% of the therapeutic procedure group (total, 0.1%). Despite marked changes in patient population and practice, the complication rates of cardiac catheterization remain very low.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11246238     DOI: 10.1002/ccd.1067

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  25 in total

1.  Complications of diagnostic cardiac catheterisation: results from a confidential inquiry into cardiac catheter complications.

Authors:  R West; G Ellis; N Brooks
Journal:  Heart       Date:  2005-11-24       Impact factor: 5.994

Review 2.  [Ultrasound diagnosis of vascular complications following transfemoral puncture].

Authors:  D A Clevert; R Kubale; T I Strautz; P M Flach; C Trumm; R T Hoffmann; M Reiser
Journal:  Radiologe       Date:  2006-07       Impact factor: 0.635

Review 3.  Echocardiographic guidance for diagnostic and therapeutic percutaneous procedures.

Authors:  Cam Tu Nguyen; Eunice Lee; Huai Luo; Robert J Siegel
Journal:  Cardiovasc Diagn Ther       Date:  2011-12

Review 4.  Con: Liver Biopsy Remains the Gold Standard to Evaluate Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.

Authors:  Daniel Berger; Vishal Desai; Sujit Janardhan
Journal:  Clin Liver Dis (Hoboken)       Date:  2019-04-30

5.  Usefulness of a Nonsuture Closure Device in Patients Undergoing Diagnostic Coronary and Peripheral Angiography.

Authors:  John T Owens; Shaun Bhatty; Robert J Donovan; Andrea Tordini; Peter Danyi; Kalpesh Patel; Jacob A Wegelin; Ion S Jovin
Journal:  Int J Angiol       Date:  2017-10-04

6.  Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders.

Authors:  Peter Ong; Anastasios Athanasiadis; Udo Sechtem
Journal:  J Vis Exp       Date:  2016-08-18       Impact factor: 1.355

7.  Complications of cardiac catheterization in adults and children with congenital heart disease in the current era.

Authors:  Yoshiki Mori; Kazuhiro Takahashi; Toshio Nakanishi
Journal:  Heart Vessels       Date:  2012-03-29       Impact factor: 2.037

Review 8.  Massive Hemorrhage from Arterial Access during Intracranial Aneurysm Stent-Assisted Embolization: Endovascular Diagnosis and Therapy.

Authors:  James T Bui; Robert Jajko; Sean P Zivin
Journal:  Semin Intervent Radiol       Date:  2015-03       Impact factor: 1.513

9.  Renal perforation and retroperitoneal hematoma: an unusual complication following cardiac catheterization.

Authors:  Soeren A Peters; Aydan Yazar; Stefan P Lemburg; Christoph M Heyer
Journal:  Int J Cardiovasc Imaging       Date:  2007-02-07       Impact factor: 2.357

Review 10.  Coronary computed tomographic angiography: current role in the diagnosis and management of coronary artery disease.

Authors:  Andrew W Bowman; Birgit Kantor; Thomas C Gerber
Journal:  Pol Arch Med Wewn       Date:  2009-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.